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ABSTRACT
BLOOMQUIST K., P. OTURAI, M. L. STEELE, L. ADAMSEN, T. MKLLER, K. B. CHRISTENSEN, B. EJLERTSEN, and S. C.
HAYES. Heavy-Load Lifting: Acute Response in Breast Cancer Survivors at Risk for Lymphedema. Med. Sci. Sports Exerc., Vol. 50,
No. 2, pp. 187–195, 2018. Purpose: Despite a paucity of evidence, prevention guidelines typically advise avoidance of heavy lifting in
an effort to protect against breast cancer–related lymphedema. This study compared acute responses in arm swelling and related
symptoms after low- and heavy-load resistance exercise among women at risk for lymphedema while receiving adjuvant taxane-based
chemotherapy. Methods: This is a randomized, crossover equivalence trial. Women receiving adjuvant taxane-based chemotherapy for
breast cancer who had undergone axillary lymph node dissection (n = 21) participated in low-load (60%–65% 1-repetition maximum,
two sets of 15–20 repetitions) and heavy-load (85%–90% 1-repetition maximum, three sets of 5–8 repetitions) upper-extremity resistance
exercise separated by a 1-wk wash-out period. Swelling was determined by bioimpedance spectroscopy and dual-energy x-ray absorp-
tiometry, with breast cancer–related lymphedema symptoms (heaviness, swelling, pain, tightness) reported using a numeric rating scale
(0–10). Order of low- versus heavy-load was randomized. All outcomes were assessed before, immediately after, and 24 and 72 h after
exercise. Generalized estimating equations were used to evaluate changes over time between groups, with equivalence between resistance
exercise loads determined using the principle of confidence interval inclusion. Results: The acute response to resistance exercise was
equivalent for all outcomes at all time points irrespective of loads lifted, with the exception of extracellular fluid at 72 h after exercise
with less swelling after heavy loads (estimated mean difference, j1.00; 95% confidence interval, j3.17 to 1.17). Conclusions: Low-
and heavy-load resistance exercise elicited similar acute responses in arm swelling and breast cancer–related lymphedema symptoms in
women at risk for lymphedema receiving adjuvant taxane-based chemotherapy. These represent important preliminary findings, which
can be used to inform future prospective evaluation of the long-term effects of repeated exposure to heavy-load resistance exercise. Key
Words: ARM SWELLING, BREAST CANCER, DOSE–RESPONSE, STRENGTH TRAINING
B
reast cancer–related arm lymphedema (BCRL) is a
chronic condition initially characterized by regional
swelling of the arm or hand due to increases in
protein-rich extracellular fluid, affecting approximately 20%
of breast cancer survivors as a consequence of treatment
(1,2). The adverse effects of BCRL are well described in the
literature, negatively affecting daily functions (3,4) and so-
cial, emotional, and psychological well-being (4,5).
More extensive surgery to the chest wall, radiotherapy,
chemotherapy, and being overweight and/or physically in-
active have been consistently associated with increased
BCRL risk (1). However, the extent of lymph node removal
is considered the strongest risk factor, with BCRL incidence
four times higher after axillary lymph node dissection
compared with sentinel-node biopsy (1). Despite the high-
quality evidence in support of specific risk factors, the
ability to predict who will develop BCRL is limited.
Historically, breast cancer survivors were advised to re-
frain from resistance exercise as a means of preventing
BCRL (6,7). However, results from systematic reviews of
clinical trials consistently indicate that resistance exercise
elicits gains in muscle strength and physical components
of quality of life without increased risk for BCRL (6–9).
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Nonetheless, more work needs to be undertaken to confirm
safety of resistance exercise, because those considered at high
risk for BCRL do not reflect the target sample of studies in-
cluded in these reviews. Specifically, only one study explic-
itly included participants undergoing chemotherapy (10), of
which 31% received adjuvant taxane-based chemotherapy.
This is of importance because generalized edema with ensu-
ing arm swelling is a known side effect to this cytostatic agent
(11). In addition, just two studies (10,12) specifically in-
cluded women at risk for BCRL who had undergone axillary
lymph node dissection, considered the greatest risk factor.
Limitations also exist with respect to exercise prescrip-
tion because resistance load has not exceeded 80% of 1-
repetition maximum (RM) or 8–12 repetitions in previous
studies evaluating resistance exercise and BCRL risk, be-
cause of concerns that heavier loads would trigger BCRL
development (6–9,13). However, exercise science literature
indicates that a dose–response relationship exists between
loads lifted and gains in muscular structure and function
with heavier loads shown to be more effective in eliciting
strength gains compared with lighter loads (14,15).
To date, two prospective studies including women with
clinically stable BCRL who had been diagnosed with breast
cancer at least a year before study inclusion have evaluated
the potential of heavier-load resistance exercise using 6–
10 RM (16,17). These studies found that the extent of arm
swelling and associated BCRL symptoms remained stable
both immediately after and 24 and 72 h after one bout of
resistance exercise (16), and after 12 wk of regular resistance
exercise irrespective of whether low or heavy loads were
lifted (17). As such, these studies provide meaningful infor-
mation for women with BCRL who have completed active
treatment (chemotherapy and radiotherapy). These findings
cannot, however, be generalized to the at-risk population
undergoing taxane-based chemotherapy.
Therefore, the purpose of this study was to undertake a
phase II trial to assess the initial lymphatic response to low-
load compared with heavy-load resistance exercise in breast
cancer survivors at risk for BCRL development. This was
undertaken by comparing acute changes in extracellular fluid,
arm volume, and associated BCRL symptoms after a session
of low- and heavy-load resistance exercise in women who
had undergone axillary lymph node dissection and were re-
ceiving taxane-based chemotherapy during the conduct of
this trial.
METHODS
Trial Design
Details of study design and methods have been previously
described (18). In summary, this was a randomized, cross-
over, equivalence trial whereby women participated in an
experimental low- and heavy-load upper-extremity resis-
tance exercise session, with a 7-d wash-out period between
sessions (Fig. 1). It was hypothesized that response would be
similar between resistance exercise loads for all outcomes.
The study protocol was approved by the Danish Data Pro-
tection Agency (30-1430) and the Danish Capital Regional
Ethics Committee (H-3-2014-147), and written informed
consent was obtained from all participants.
Participants
A convenience sample of women receiving standard ad-
juvant chemotherapy for stage I–III breast cancer were
screened for eligibility (918 yr of age, first diagnosis of
breast cancer, unilateral breast surgery, axillary node dis-
section) at the Copenhagen Centre for Cancer and Health
and from a wait list to the Body & Cancer program (18,19)
at the University Hospitals Centre for Health Research be-
tween March 2015 and December 2016. Women with a
known clinical diagnosis of lymphedema or who had con-
ditions limiting resistance exercise of the upper extremities
(e.g., fibromyalgia, frozen shoulder) or who had participated
in regular upper-extremity heavy resistance exercise (91 per
week) during the last month were excluded (Fig. 1).
Those meeting eligibility were assessed for BCRL status
by the first author (K.B.), after the third cycle of chemo-
therapy. BCRL was assessed using bioimpedance spectros-
copy (BIS; SFB7; Impedimed, Brisbane, Australia [16,20,21])
and a visual inspection to detect differences in swelling be-
tween arms (Common Toxicity Criteria v3.0 [2]). Those with
evidence of lymphedema according to standardized protocols
for BIS (L-Dex 910) or visual inspection were then referred
to a lymphedema therapist for further assessment and were
excluded from participating in the study.
Exercise Sessions
All participants completed two familiarization sessions,
followed by two experimental sessions (low- and heavy-load
sessions) at exercise facilities located at the research center.
All resistance exercise sessions lasted approximately 30 min
including a 10-min aerobic-based warm-up (rowing or
cross-trainer) at low-moderate intensity. All sessions were
supervised by the first author (K.B.) to ensure consistency of
warm-up intensity and order of resistance exercises performed.
None of the participants wore compression sleeves. During
the first familiarization session, participants were introduced
to four upper-extremity exercises consisting of the biceps curl
performed with free weights, followed by the chest press,
latissimus pull down, and triceps extension using resistance
exercise machines (Technogym, Gamettola, Italy). Hereaf-
ter, a 1RM strength test was performed in each exercise.
During the second session, one set of 10–15 repetitions was
performed, followed by a new 1RM strength test. Subse-
quent resistance exercise prescription during the experi-
mental sessions was based on these values. After completion
of the familiarization sessions, resistance exercise load order
for the experimental sessions was randomly allocated (i.e.,
low or heavy load first) using a computer-generated random
http://www.acsm-msse.org188 Official Journal of the American College of Sports Medicine
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sequence (1/1 ratio). Women then participated in the experi-
mental sessions, which entailed the 10-min aerobic-based
warm-up, followed by the four resistance-based exercises.
Resistance exercise load corresponded to 60%–65% 1RM
(two sets of 15–20 repetitions) for the low-load session and
85%–90% 1RM (three sets of 5–8 repetitions) for the heavy-
load session. Participants were instructed to work to muscle
fatigue (until they were unable to maintain appropriate tech-
nique) within the prescribed range and with rest periods of
60–90 s between sets.
The experimental sessions were consistently performed
on the same day of the week and at the same time of day,
with all outcomes assessed before, immediately after (within
30 min), and 24 and 72 h after resistance exercise sessions.
Blinded data collection was performed by medical technicians.
Participants were instructed to maintain normal upper-body
activities during the experimental period and to refrain from
extraordinary activities involving the upper extremities.
Primary Outcome
Extracellular fluid. BIS was used to directly measure
and compare the impedance of extracellular fluid in the up-
per extremities to electrical currents at a range of frequencies
according to the manufacturer_s software (20,21). Using the
principle of equipotentials, four single-tab electrodes were
placed in a tetrapolar arrangement and participants were
measured in supine, with arms and legs abducted from the
trunk with palms facing down. To ensure accuracy, standard
protocols from the manufacturer were followed (e.g., empty
bladder, no excessive exercise or caffeine consumption
within 2 h). The ratio of impedance (at R0) between the at-risk
FIGURE 1—Participant flow through resistance exercise and data collection sessions. RE, resistance exercise; SNB, sentinel-node biopsy.
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and nonaffected arm was calculated and converted into an
L-Dex score taking arm dominance into account.
Secondary Outcomes
Interarm volume percent difference. Measurements
of arm volume were obtained using dual-energy x-ray ab-
sorptiometry (DXA; Lunar Prodigy Advanced Scanner; GE
Healthcare, Madison, WI). DXAmeasures tissue composition
using a three-compartment model that is sensitive to changes
in upper-extremity tissue composition (21,22). Using previously
derived densities for fat (0.9 gImLj1), lean mass (1.1 gImLj1)
and bone mineral content (1.85 gImLj1), DXA measure-
ments were converted into estimated arm volumes. Lying
supine on the scan table with the arm separated from the
trunk, each arm was scanned separately. If necessary, a Velcro
band or the free arm was placed over the breast to ensure space
between the arm and trunk. Small animal software (ENCORE
version 14.10) was used to analyze the scans as described by
Gjorup et al. (21,22). All scans were analyzed by a clinical ex-
pert (P.O.) in DXA scan analysis. Interarm volume percent dif-
ferences (at-risk arm minus unaffected arm/unaffected arm 
100) were then calculated for each participant.
Subjective assessment of BCRL symptoms. The
severity of symptoms related to BCRL was monitored using
a numeric rating scale. Participants rated their perceptions of
swelling, heaviness, pain, and tightness independently for
each arm on a scale from 0 (no discomfort) to 10 (very se-
vere discomfort) (16,23).
Sample Size Calculation
Sample size calculation was based on changes in L-Dex
scores between baseline and 72 h after resistance exercise
sessions. From the results of Cormie et al. (16), it was hy-
pothesized that the SD in the distribution of L-Dex scores
would be 1.9 units. On the basis of clinical experience, for
patients with BCRL, a change score of 2.0 L-Dex units would
be considered clinically relevant. However, in the at-risk
population, no published normative change scores exist, nor
does evidence regarding a threshold for a clinically significant
acute change. A change in 2.0 L-Dex units was deemed too
small in the at-risk population, on the basis of the assumption
that larger fluctuations would be seen within the normal range
without clinical relevance. Therefore, a priori, we set the
clinically relevant threshold for change as being 3.0 L-Dex
units. Thus, if there was no difference between intensities,
then 18 participants were needed to be 90% sure that the
limits of a two one-sided 95% confidence interval (CI) would
exclude a difference in means of more than 3.0 L-Dex units.
To allow for dropouts, 21 women were recruited.
Statistical Analyses
Descriptive statistics included counts (and percentages) for
categorical values and mean T SD for normally distributed
continuous variables, unless otherwise noted. Individual
responses to resistance exercise loads were first assessed
descriptively, including determination of the proportion that
exceeded the predetermined clinically relevant threshold.
Next, generalized estimating equations (GEE) (24) were
used to evaluate the effects of time (pre-, post-, 24 and 72 h
post-) and load (low/heavy load), and a time–load interac-
tion. An exchangeable correlation structure was used to
model the within-subject correlation of repeated measure-
ments over time and across intensities.
To assess equivalence, the principle of CI inclusion was
used to calculate one-sided upper and lower 95% confidence
limits for all outcomes (25) (reported as two-sided 90%
confidence limits). If the interval between the upper and
lower confidence limits was within the predetermined
equivalence margin, equivalence between resistance exer-
cise intensities was declared. For the primary outcome, the
margin of equivalence was set at T3.0 L-Dex units. On the
basis of the findings by Stout et al. (26) that volume in-
creases of 93% from preoperative measures were indicative
of subclinical BCRL, an equivalence margin of T3.0% was
used for interarm volume percent differences. For all sub-
jective measures, interarm differences were calculated and
an equivalence margin was set at T1.0 points. This threshold
was based on previous findings that suggest a 2-point or
30% change to be clinically meaningful for pain (23). Per-
protocol principles were applied because this is considered
the most conservative approach for determining equivalence (27).
Analyses were conducted in R version 3.3.1 (28) using geepack
1.2.0.1 for GEE modeling (29).
RESULTS
Participants. From the 216 women assessed for eligi-
bility, 21 were eligible and consented to participate. Of
these, 3 dropped out before initiation of the experimental
exercise sessions because of time constraints and injury (Fig. 1),
1 discontinued participation after the 24-h postexercise as-
sessment in week 1 because of logistical considerations, and
17 (81%) completed all data collections.
Characteristics of the study population are presented in
Table 1. Average age of participants was 45 yr, and mean
body mass index (BMI) was 25.3 kgImj2, with 11 (53%)
participants presenting with a BMI of Q25.0 kgImj2. On av-
erage, women had 22 axillary lymph nodes removed during
axillary node dissection and 62% of the participants had re-
ceived a mastectomy. As per eligibility criteria, all partici-
pants received adjuvant taxane-based chemotherapy during
the experimental sessions; however, the first 10 participants
received docetaxel, whereas the last 11 received paclitaxel,
because standard chemotherapy changed midway through the
study period.
Individual responses to resistanceexercise sessions.
For L-Dex and interarm volume outcomes, individual re-
sponses to resistance exercise sessions varied with no apparent
group trend observed (Fig. 2A, B). For BCRL symptoms, we
found that most participants were asymptomatic before
http://www.acsm-msse.org190 Official Journal of the American College of Sports Medicine
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exercise and remained asymptomatic throughout the subse-
quent data collections irrespective of loads lifted (Fig. 2C–F).
Deviations from predetermined thresholds. When
data were described according to clinically relevant changes
from preexercise, 16 women (89%) had experienced fluc-
tuations in extracellular fluid beyond the predetermined
threshold at one time point or more, ranging from j8.7 to
6.8 L-Dex units. Almost twice as many had fluctuations
after the low-load session (n = 12 (71%)) compared with the
high-load session (n = 8 (44%); Table 2). Increases above
the clinical threshold were observed for seven women (41%)
after the low-load session, two of which had increased pre–
post measures that remained elevated above the clinically
meaningful threshold at 24 and 72 h after exercise (Fig. 2A).
None of these women had clinically meaningful increases in
L-Dex after heavy-load resistance exercise. Four women
(22%) had increases in L-Dex after the heavy-load session.
Of these, two were observed immediately after the heavy
load session (one of these also showed an increase in
interarm volume percent difference; increases had dissipated
in both cases by the 24-h post–follow-up), whereas the other
two were observed at 72 h after exercise.
For interarm volume, four (24%) women experienced
clinically meaningful fluctuations ranging from j4.1% to
4.6%. Three (18%) participants experienced increases after
heavy-load exercise, with two seen immediately after exer-
cise and one at 24 h after exercise (Fig. 2B). One participant
(6%) experienced decreases after the low-load session im-
mediately after exercise (Table 2). None of these observa-
tions coincided with other outcome measures (except for the
previously described L-Dex pre–post measure).
For BCRL symptoms, we found that eight (44%) women
responded with fluctuations ranging from j7 to 3 units.
Specifically, six (33%) women reported decreases in symp-
toms, with reductions observed after exercise and sustained
over the subsequent time points, and were equally distrib-
uted between resistance exercise load conditions (Table 2).
Increases in symptoms were reported by two (11%) women.
One woman reported increases in pain and tightness at 24-h
post–heavy-load exercise (Fig. 2D, E), whereas the other par-
ticipant experienced increases in heaviness and swelling after
exercise after the heavy-load session (Fig. 2C, F), and an in-
crease in pain 24 h after the low-load session (Fig. 2D). None
of these increases were sustained at the 72-h postsession
follow-up.
An overview of unadjusted means and SD for all out-
comes at each time point is presented in Table 3.
L-Dex. The estimated mean difference between re-
sistance exercise loads and associated two-sided 90% CI for
L-Dex scores were contained within the predetermined
equivalence margin of T3.0 units immediately and 24 h after
resistance exercise indicating equivalence between intensi-
ties (j0.97 (j2.09 to 0.16) and j0.14 (j1.63 to 1.35),
respectively; Table 4). However, at 72 h after exercise, the
lower CI exceeded j3.0 and equivalence between low- and
heavy-load intensities could not be declared, favoring heavy-
load resistance exercise.
Interarm volume percent difference. Equivalence be-
tween intensities was observed at all time points for interarm
volume percent differences, as estimated mean differences and
90% CI were within the T3.0 margin of equivalence (Table 4).
BCRL symptoms. Equivalence between resistance exer-
cise intensities was found for all BCRL symptoms at all time
points, as estimated mean differences and associated 90% CI
were within the equivalence margin of T1.0 (Table 4).
No adverse events related to exercise (i.e., sprains or
strains) were reported. However, two (11%) participants were
advised to seek evaluation by a lymphedema therapist at the
end of the study period because L-Dex scores had exceeded
10 (Fig. 2A). One participant had a preexercise L-Dex score
of 7.9 in week 1. Upon instigating the low-load session at
week 2, an L-Dex score of 11.7 was observed, with subse-
quent measures decreasing. The other participant initiated the
heavy-load session at week 1 with a preexercise L-Dex score
of 3.8, and subsequent measures fluctuating less than 5.0 units.
At week 2, a preexercise L-Dex score of 9.5 was observed that
increased to 12.7 after exercise, with decreasing subsequent
measures. Notably, this participant suffered from rapid weight
gain due to generalized edema between weeks 1 and 2 that was
effectively treated with diuretics. All other outcomes were
within the predetermined clinical thresholds at all time points
for both of these participants.
DISCUSSION
The findings of this study support the hypothesis that acute
changes in extracellular fluid, arm volume, and BCRL-related
symptoms were similar irrespective of whether low- or
heavy-load upper-extremity resistance exercise was performed
during adjuvant taxane-based chemotherapy in women with
axillary lymph node dissection.
This is the first study to prospectively investigate lym-
phatic response to resistance exercise with heavy loads
TABLE 1. Baseline characteristics of participants (n = 21).
Variables Mean T SD/Median (Range)
Age, yr 45.3 T 9.2/46 (23–60)
BMI, kgImj2 25.3 T 4.7
Cancer stage, n (%)
II 15 (71)
III 6 (29)
Tumor size, mm 21.5 T 12.9/18 (7–62)
Breast surgery, n (%)
Lumpectomy 8 (38)
Mastectomy 13 (62)
Surgery on dominant side, n (%) 11 (52)
Axillary lymph nodes removed 21.7 T 7.8
Metastatic lymph nodesa 5.7 T 7/2 (1–25)
Seroma drainage 5.5 T 3.4
Chemotherapy, n (%)
3-wk CE  3 Y 3-wk docetaxel  3 10 (48)
3-wk CE  3 Y 1-wk paclitaxel  9 11 (52)
Axillary webbing at screening, n (%) 8 (38)
L-Dex at screening j0.08 T 2.23
aMicrometastase and macrometastase.
CE, cyclophosphamide and epirubicin.
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(85%–90% 1RM, for 5–8 repetitions) in breast cancer sur-
vivors at risk for developing BCRL. Findings are consistent
with observations from a cross-sectional study (n = 149) that
showed no association between participation in a multi-
modal exercise intervention including heavy-load resistance
exercise during taxane-based chemotherapy and BCRL de-
velopment (30). Furthermore, our results are consistent with
the findings of Cormie et al. (16), demonstrating that par-
ticipation in a bout of resistance exercise using 6–10RM
loads did not acutely exacerbate swelling or BCRL symp-
toms in women with stable lymphedema. As such, this lends
credibility to the results of the present study.
The equivalence design was considered the most appro-
priate for addressing our research question and was formal-
ized by defining equivalence margins for all outcomes.
Equivalence margins ideally represent the maximum clini-
cally acceptable difference that one is willing to accept in
return for the secondary benefits of a new therapy (27),
FIGURE 2—Individual response related to low- and heavy-load resistance exercise sessions for all outcomes (n = 17). A, Heavy-load L-Dex pre-, post-,
and 24 h (n = 18). In subplots C–F, heavy-load breast cancer–related lymphedema symptoms preexercise and postexercise (n = 18). n refers to the
number of participants with a symptom score of 0 at all time points.
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which in this study was heavy-load resistance exercise. The
value and impact of establishing equivalence depend on how
well the equivalence margin can be justified in terms of
relevant evidence and clinical judgment, where a narrower
equivalence margin makes it more difficult to establish
equivalence (27). The equivalence margin for the primary
outcome was estimated as 3.0 L-Dex units. A priori, the
threshold was chosen on the basis of change scores consid-
ered to be clinically relevant for persons with BCRL, be-
cause no known normative change scores existed for persons
without BCRL. However, new normative data recently
published indicate that L-Dex scores fluctuate between 9
and 11 units (31). This is in line with our results, finding that
16 (89%) participants experienced deviations from the pre-
determined L-Dex threshold. As such, although the equi-
valence margin for this outcome likely was unnecessarily
narrow, this adds confidence to our findings. Furthermore,
had we used broader L-Dex equivalence margins, the 90% CI
at 72 h after exercise would have fallen within the margin of
equivalence. Therefore, in light of these new normative data,
it is likely that response to resistance exercise intensities was
equivalent at all time points.
Equivalence was also established for all assessed BCRL
symptoms at all time points, and although fluctuations be-
yond the predetermined thresholds were observed, it should
be highlighted that the majority (82%) of these deviations
indicated reductions in severity after resistance exercise with
both intensities. This is relevant because symptoms can be
the earliest indicator of an ensuing BCRL (32).
When interpreting the findings, several limitations should
be considered. In this study, participants were excluded if
they presented with evidence of BCRL according to stan-
dardized protocols for BIS (L-Dex 910) or visual inspection.
It is, however, possible that these women were experiencing
transient increases in extracellular fluid, either as a conse-
quence of surgery or in response to chemotherapy (33), and/or
may have been at greatest risk for developing BCRL. As
such, these women may have been more likely than those
included in the study to demonstrate changes in extracellular
fluid, and by excluding them, it may have been easier to find
equivalence between loads. Moreover, activities undertaken
by participants within the 3 d after the bout of low- or high-
load resistance may have influenced data collected at 24 or
72 h post–exercise session. However, participants were ad-
vised to maintain normal activities throughout the study
period, and efforts were made to standardize treatment bur-
den by placing exercise bouts and consecutive data collec-
tions between chemotherapy cycles.
Strengths of this study include that all participants had re-
ceived axillary node dissection, considered the largest single
risk factor for developing BCRL, lending generalizability to
TABLE 4. Equivalence between resistance exercise intensities for all outcomes (n = 17).
Estimated Mean Differenceb Equivalence 90% CI
L-Dex (T3.0)a
Postexercise j0.97 j2.09 to 0.16
24 h postexercise j0.14 j1.63 to 1.35
72 h postexercise j1.00 j3.17 to 1.17
Interarm volume % difference (T3.0)a
Postexercise 0.21 j0.89 to 1.31
24 h Postexercise 1.09 0.41 to 1.78
72 h Postexercise 0.96 j0.09 to 2.02
Interarm difference for pain (T1.0)a
Postexercise 0 j0.43 to 0.43
24 h postexercise j0.06 j0.58 to 0.46
72 h postexercise j0.06 j0.61 to 0.49
Interarm difference for heaviness (T1.0)a
Postexercise 0.24 j0.23 to 0.70
24 h postexercise 0.18 j0.32 to 0.67
72 h postexercise 0.24 j0.38 to 0.85
Interarm difference for tightness (T1.0)a
Postexercise j0.06 j0.45 to 0.34
24 h postexercise j0.11 j0.50 to 0.27
72 h postexercise 0.20 j0.37 to 0.77
Interarm difference for swelling (T1.0)a
Postexercise 0 j0.33 to 0.33
24 h postexercise 0 j0.33 to 0.33
72 h postexercise 0.06 j0.42 to 0.54
Boldface indicates that equivalence was not demonstrated.
aEquivalence margin.
bEstimated mean difference calculated using a GEE model with heavy load as comparator
(heavy minus low).
TABLE 2. Number (%) of participants exceeding equivalence margin from preexercise to
immediately postexercise and 24 and 72 h after exercise for all outcomes (n = 17).
¸ Pre–Post ¸ Pre–24 h Post ¸ Pre–72 h Post
L-Dex
Heavy load 2j (11%)a 2, (11%)a 2j (12%), 3, (18%)
Low load 4j (24%), 1, (6%) 3j (18%), 4, (24%) 4j (24%), 4, (24%)
% interarm difference
Heavy load 2j (12%) 1j (6%) 1j (6%)
Low load 1, (6%) 0 1, (6%)
Pain
Heavy load 2, (11%)a 1j (6%), 2, (12%) 2, (12%)
Low load 2, (12%) 1j (6%), 1, (6%) 1, (6%)
Heaviness
Heavy load 1j (6%), 1, (6%)a 1, (6%) 2, (12%)
Low load 2, (12%) 2, (12%) 2, (12%)
Tightness
Heavy load 0a 1j (6%), 1, (6%) 1, (6%)
Low load 1, (6%) 1, (6%) 2, (12%)
Swelling
Heavy load 1j (6%), 1, (6%)a 1, (6%) 1, (6%)
Low load 0 1, (24%) 2, (12%)
j, higher than equivalence margin; ,, lower than equivalence margin.
an = 18.
TABLE 3. Extent of swelling and breast cancer–related lymphedema symptoms for all
outcomes (n = 17).
Preexercise Postexercise
24 h
Postexercise
72 h
Postexercise
L-Dex score
Heavy load 1.7 T 3.3a 1.9 T 3.4a 1.0 T 2.6a 0.8 T 3.9
Low load 0.8 T 5.0 1.9 T 5.1 0.2 T 4.4 0.7 T 3.6
% interarm difference
Heavy load 0.5 T 4.4 1.0 T 4.0 1.4 T 4.2 1.1 T 4.3
Low load 1.3 T 4.1 1.6 T 4.8 1.0 T 4.2 0.8 T 4.4
Pain
Heavy load 0 (j1, 6)a 0 (j1, 2)a 0 (j1, 3) 0 (0, 2)
Low load 0 (0, 5) 0 (j1, 1) 0 (j1, 2) 0 (j1, 4)
Heaviness
Heavy load 0 (0, 2)a 0 (0, 4)a 0 (0, 2) 0 (0, 2)
Low load 0 (0, 5) 0 (0, 3) 0 (0, 2) 0 (0, 2)
Tightness
Heavy load 0 (0, 6)a 0 (0, 5)a 0 (0, 3) 0 (0, 3)
Low load 0 (0, 7) 0 (0, 8) 0 (0, 8) 0 (0, 3)
Swelling
Heavy load 0 (0, 2)a 0 (0, 3)a 0 (0, 2) 0 (0, 2)
Low load 0 (0, 2) 0 (j1, 3) 0 (0, 2) 0 (0, 2)
L-Dex and interarm volume presented as mean T SD. BCRL-related symptoms presented
as median (range).
an = 18.
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breast cancer survivors at BCRL risk. Furthermore, because
all exercise sessions took place during the taxane-based cy-
cles of chemotherapy, the results extend to acute bouts of
low- or high-load resistance-type activities during taxane-
based treatment. Finally, validated objective measurement
methods sensitive to changes in extracellular fluid were used,
and all data collections and analyses were blinded to resis-
tance load lending credibility to the results.
Findings from this study are clinically relevant for a
number of reasons. First, the safety of resistance exercise in
regard to BCRL risk has previously been established on the
basis of exercise prescription using low- to moderate loads.
For example, some resistance exercise programs started with
little or no weight and slowly progressed with the smallest
weight increment possible until loads lifted corresponded to
weights that successfully could be lifted a minimum of 15
repetitions (12) or within a range of 10–12 repetitions (34),
whereas others used loads corresponding to 60%–80% 1RM
at 8–12 repetitions (10,13). As such, this work adds new
information, providing initial evidence that resistance exer-
cise prescription also can include heavier loads, specifically
corresponding to 85%–90% 1RM at 5–8 repetitions.
Second, a considerable rationale exists for participating
in resistance exercise during chemotherapy because it has
been found to elicit increases in muscle strength (10,35,36),
lean body mass (10), and self-esteem (10) as well as at-
tenuating fatigue and quality of life (36). Moreover, it has
been hypothesized that resistance exercise reduces taxane-
related edema (37) through the effects of the muscle pump,
and it is plausible that participation in heavy-load resistance
exercise may instigate more effective lymphatic function
change than low-load resistance exercise, and in doing so,
potentially have a greater effect on reducing BCRL risk. As
such, results from this study provide the necessary platform
for future studies to explore whether additional benefits can
be gained from repeated bouts of heavy-load resistance
exercise during adjuvant taxane-based chemotherapy. Fi-
nally, breast cancer survivors commonly receive risk re-
duction advice cautioning against heavy lifting (38). This
study, however, found no evidence to suggest that partici-
pation in activities of daily living that include intermittent
heavy-load lifting need be avoided. Furthermore, a varied
response to resistance exercise was observed for both in-
tensities. This highlights the importance of an individualized
approach to resistance exercise prescribed in accordance
with signs and symptoms of BCRL, as well as an individu-
alized approach to the risk reduction advice given to breast
cancer survivors.
In conclusion, the acute lymphatic response was similar
irrespective of whether low- or heavy-load resistance exer-
cise was undertaken in women with axillary node dissection
at risk for BCRL during adjuvant taxane-based chemother-
apy. Future research needs to now investigate the longer-
term response to regular heavy-load resistance exercise. In
the interim, these findings challenge existing risk reduction
advice concerning avoidance of heavy lifting and suggest
that breast cancer survivors should be encouraged to par-
ticipate in normal daily activities and to act accordingly if
changes in sensations or BCRL symptoms are observed.
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